At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02367 GIANT BIOGENE
Trading 01-12 13:19:36
34.720
+0.300
+0.87%
High34.920Low34.080Vol3.51M
Open34.860D1 Closing34.420Amplitude2.44%
Mkt Cap37.19BTradable Cap37.19BTotal Shares1.07B
T/O120.87MT/O Rate0.33%Tradable Shares1.07B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.76 Million on January 9
Stock News  ·  01-09 19:08
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.76 Million on January 9
Hong Kong Stock Buyback Report | January 9
Stock News  ·  01-09
Hong Kong Stock Buyback Report | January 9
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.78 Million on January 7
Stock News  ·  01-07
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.78 Million on January 7
Zhito ng Hong Kong Stock 52-Week Highs and Lows Statistics | January 2nd
Stock News  ·  01-02
Zhito ng Hong Kong Stock 52-Week Highs and Lows Statistics | January 2nd
Hong Kong Stocks 52-Week Highs and Lows Statistics | December 31
Stock News  ·  2025-12-31
Hong Kong Stocks 52-Week Highs and Lows Statistics | December 31
HK Stock Movement | GIANT BIOGENE (02367) Falls Over 3% in Afternoon Trading; Institutions State Company's Investment Thesis Has Shifted from Growth to Strategic Adjustment, Lacking Clear Rebound Catalyst
Stock News  ·  2025-12-30
HK Stock Movement | GIANT BIOGENE (02367) Falls Over 3% in Afternoon Trading; Institutions State Company's Investment Thesis Has Shifted from Growth to Strategic Adjustment, Lacking Clear Rebound Catalyst
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.81 Million on December 29
Stock News  ·  2025-12-29
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.81 Million on December 29
HK Stock Buyback Summary | Dec 24
Stock News  ·  2025-12-24
HK Stock Buyback Summary | Dec 24
Giant Biogene Holding (SEHK:2367): Assessing Valuation After Launching a 10% Share Buyback Program
Simply Wall St.  ·  2025-12-23
Giant Biogene Holding (SEHK:2367): Assessing Valuation After Launching a 10% Share Buyback Program
GIANT BIOGENE (02367) Repurchases 400,000 Shares for Approximately HK$14.43 Million on December 22
Stock News  ·  2025-12-22
GIANT BIOGENE (02367) Repurchases 400,000 Shares for Approximately HK$14.43 Million on December 22
HK Stock Buyback Summary | December 18
Stock News  ·  2025-12-18
HK Stock Buyback Summary | December 18
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.97 Million on December 17
Stock News  ·  2025-12-17
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.97 Million on December 17
Morgan Stanley Adjusts Giant Biogene Holding's Price Target to HK$42 from HK$78, Keeps at Overweight
MT Newswires Live  ·  2025-12-17
Morgan Stanley Adjusts Giant Biogene Holding's Price Target to HK$42 from HK$78, Keeps at Overweight
Did Giant Biogene’s New Buyback Plan Just Shift Giant Biogene Holding's (SEHK:2367) Investment Narrative?
Simply Wall St.  ·  2025-12-17
Did Giant Biogene’s New Buyback Plan Just Shift Giant Biogene Holding's (SEHK:2367) Investment Narrative?
HKEX Share Buyback Summary | December 17
Stock News  ·  2025-12-17
HKEX Share Buyback Summary | December 17
GIANT BIOGENE (02367) Repurchases 400,000 Shares for Approximately HK$13.92 Million on December 15
Stock News  ·  2025-12-15
GIANT BIOGENE (02367) Repurchases 400,000 Shares for Approximately HK$13.92 Million on December 15
Giant Biogene Holding (SEHK:2367): Valuation Check After New Buyback Plan and Fresh Broker Buy Ratings
Simply Wall St.  ·  2025-12-15
Giant Biogene Holding (SEHK:2367): Valuation Check After New Buyback Plan and Fresh Broker Buy Ratings
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$14.04 Million on December 12
Stock News  ·  2025-12-12
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$14.04 Million on December 12
Hong Kong Stock Buyback Summary | December 12
Stock News  ·  2025-12-12
Hong Kong Stock Buyback Summary | December 12
Hong Kong Stocks Hit 52-Week Highs and Lows | Dec 11
Stock News  ·  2025-12-11
Hong Kong Stocks Hit 52-Week Highs and Lows | Dec 11

Introduction

Company Name.
GIANT BIOGENE
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Giant Biogene Holding Co Ltd is an investment holding company primarily engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The Company mainly conducts its businesses in domestic market.
Issue price:
--